KRISTIN LUKE: Open Payments
NPI 1992018493 · HERKIMER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,192 in 33 payments from 10 companies in 2025. Trend: 2023 $315 · 2024 $354 · 2025 $1,192
Food & beverage: $1,192
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $370 |
| Sequel Med Tech, LLC | 2 | $266 |
| Abbott Laboratories | 5 | $171 |
| Lilly USA, LLC | 7 | $148 |
| Dexcom, Inc. | 1 | $125 |
| Boston Scientific Corporation | 1 | $27 |
| Insulet Corporation | 1 | $26 |
| Amphastar Pharmaceuticals, Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, TWIIST, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, ZEPBOUND, General - Pain Management, Omnipod, MOUNJARO.
Industry payments across NY — which companies pay providers there.
